Journey to the FDA approval for bile duct cancer will be well worth the wait. It is likely to re-rate OSL to the next level, IMO. It is the 1) inflection point according to Nigel.
You can google FDA CDRH oncosil to follow that journey. I think we are almost there. Dossier recently completed and update expected soon. Old diagram of this journey below.
Journey to the FDA approval for bile duct cancer will be well...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.035(3.48%) |
Mkt cap ! $13.79M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 97.0¢ | $66.41K | 66.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3907 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 3000 | 1 |
View Market Depth
| Last trade - 15.47pm 23/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |